BOLD logo

Boundless Bio (BOLD)

Profile

Full Name

Boundless Bio, Inc.

Ticker Symbol

BOLD

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 20, 2016

Indexes

Not included

Website

http://boundlessbio.com

Employees

64

Key Details

Price

$1.42(+8.40%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$3.85(-73.20% YoY)

PE ratio

-

Next earnings date

May 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.42
BOLD price is $1.42

30-Day Relative Volume

0.87
BOLD 30-day relative volume is 0.87

Price Performance

Price Most recent change

+8.4%
BOLD price was up +8.4% on Apr 17, 2025

Price YTD change

-51.03%
BOLD price is down -51.03% since January 1st

Price 1-year change

-87.42%
BOLD price is down -87.42% year-on-year

Price 3-year change

-
BOLD price 3-year change is unknown

Price Range

Price All-time high

$15.24
BOLD price is currently -90.68% below its historical high of $15.24

Price 3-year low

$1.06
BOLD price is currently +33.96% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$31.67M
BOLD market capitalization is $31.67 million

Market cap 3-year change

-
BOLD market capitalization 3-year change is unknown

Market cap All-time high

$316.91M
BOLD market capitalization is currently -90.01% below its historical high of $316.91 million

Market cap sector rank

32.1%
BOLD market capitalization is higher than 32.1% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.27%
BOLD shares outstanding is up +0.27% year-on-year

Shares Outstanding 3-Year Change

-
BOLD shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.42
BOLD beta is 1.42

200-day SMA

$2.78
BOLD price is currently -48.87% below its 200-day simple moving average

50-day SMA

$1.69
BOLD price is currently -15.95% below its 50-day simple moving average

RSI

47.82
BOLD 14-day relative strength index is 47.82

Volume

0.87
BOLD 30-day relative volume is 0.87

ATR

$0.15
BOLD average true range is $0.15

10-day Historical Volatility

107.16%
BOLD 10-day historical volatility is 107.16%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
BOLD annual revenue value is unknown

Revenue Analysts estimate

-
BOLD annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
BOLD annual revenue 1-year change is unknown

Revenue Sector rank

-
BOLD annual revenue is unknown

EPS

EPS

-$3.85
BOLD annual earnings per share is -$3.85

EPS Analysts estimate

-$3.29
BOLD annual earnings per share is currently +17.02% higher than the consensus analysts' forecast

EPS 1-year change

-73.2%
BOLD annual earnings per share is down -73.2% year-on-year

EPS Sector rank

23.45%
BOLD annual earnings per share is higher than 23.45% of companies in Healthcare sector

Profit

Gross profit

-
BOLD annual gross profit value is unknown

Gross margin

-
BOLD annual gross profit margin value is unknown

Operating profit

-$73.27M
BOLD annual operating income is -$73.27 million

Operating margin

-
BOLD annual operating profit margin value is unknown

Net income

-$65.36M
BOLD annual net profit is -$65.36 million

Net margin

-
BOLD annual net profit margin value is unknown

Expenses

Total expenses

$73.27M
BOLD annual total expenses is $73.27 million

Operating expenses

$73.27M
BOLD annual total operating expenses is $73.27 million

Cost of goods sold

-
BOLD annual cost of goods sold value is unknown

Selling, general & administrative expenses

$18.00M
BOLD annual SGA is $18.00 million

Depreciation and amortization

$1.09M
BOLD annual depreciation & amortization is $1.09 million

Interest expense

-
BOLD annual interest expense value is unknown

Income tax

-
BOLD annual income tax value is unknown

EBIT & EBITDA

EBIT

-$73.27M
BOLD annual earnings before interest & taxes is -$73.27 million

EBITDA

-$72.18M
BOLD annual EBITDA is -$72.18 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$206.41M
BOLD annual total assets is $206.41 million

Non current assets

$52.02M
BOLD annual long term assets is $52.02 million

Current assets

$154.39M
BOLD annual total current assets is $154.39 million

Cash and cash equivalents

$26.59M
BOLD annual cash & cash equivalents is $26.59 million

Accounts receivable

-
BOLD annual accounts receivable value is unknown

Inventory

-
BOLD annual inventory value is unknown

Liabilities

Total liabilities

$55.77M
BOLD annual total liabilities is $55.77 million

Long term liabilities

$47.63M
BOLD annual total long term liabilities is $47.63 million

Current liabilities

$8.13M
BOLD annual total current liabilities is $8.13 million

Accounts payable

$1.27M
BOLD annual accounts payable is $1.27 million

Debt

Total debt

$47.63M
BOLD annual total debt is $47.63 million

Total debt 1-year change

+2070.02%
BOLD annual total debt is up +2070.02% year-on-year

Long term debt

$47.63M
BOLD annual long term debt is $47.63 million

Short term debt

$0.00
BOLD annual short term debt is $0.00

Equity & Capital

Shareholders equity

$150.64M
BOLD annual stockholders equity is $150.64 million

Book value

$150.64M
BOLD annual book value is $150.64 million

Retained earnings

-$201.47M
BOLD annual retained earnings is -$201.47 million

Working capital

$146.25M
BOLD annual working capital is $146.25 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$60.84M
BOLD annual cash flow from operations is -$60.84 million

Cash from operations 1-year change

-29.85%
BOLD annual cash flow from operations is down -29.85% year-on-year

Cash from investing

-$26.10M
BOLD annual cash flow from investing activities is -$26.10 million

Cash from investing 1-year change

+31.78%
BOLD annual cash flow from investing activities is up +31.78% year-on-year

Cash from financing

$89.82M
BOLD annual cash flow from financing activities is $89.82 million

Cash from financing 1-year change

-8.25%
BOLD annual cash flow from financing activities is down -8.25% year-on-year

CAPEX

CAPEX

-
BOLD annual capital expenditures value is unknown

CAPEX 1-year change

-
BOLD annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$63.38M
BOLD annual free cash flow is -$63.38 million

Free cash flow 1-year change

-33.46%
BOLD annual free cash flow is down -33.46% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
BOLD annual gross profit margin value is unknown

Operating margin

-
BOLD annual operating profit margin value is unknown

Net margin

-
BOLD annual net profit margin value is unknown

ROA & ROE

ROA

-31.67%
BOLD annual return on assets is -31.67%

ROE

-43.39%
BOLD annual return on equity is -43.39%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
BOLD price to earnings ratio value is unknown

PE ratio Sector rank

-
BOLD price to earnings ratio is unknown

PB Ratio

PB ratio

0.21
BOLD price to book ratio is 0.21

PB ratio Sector rank

20.12%
BOLD price to book ratio is higher than 20.12% of companies in Healthcare sector

PS Ratio

PS ratio

-
BOLD price to sales ratio value is unknown

PS ratio Sector rank

-
BOLD price to sales ratio is unknown

Enterprise value

Enterprise value

$52.71M
BOLD enterprise value is $52.71 million

Enterprise value Sector rank

42.15%
BOLD enterprise value is higher than 42.15% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.73
BOLD EV/EBITDA is -0.73

EV/EBITDA Sector rank

47.52%
BOLD EV/EBITDA is higher than 47.52% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

18.98
BOLD annual current ratio is 18.98

Quick ratio

-
BOLD annual quick ratio value is unknown

Leverage

Debt to equity

0.32
BOLD annual debt to equity ratio is 0.32

Interest coverage ratio

-
BOLD annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
BOLD piotroski f-score value is unknown

Altman Z-Score

-
BOLD altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Dec 13, 24 Guggenheim
Neutral
Apr 22, 24 Piper Sandler
Overweight
Apr 22, 24 Leerink Partners
Outperform
Apr 22, 24 Guggenheim
Buy

Institutional Ownership

Similar stocks

SCLX logo
Scilex Holding (SCLX)
Cadrenal Therapeutics (CVKD)
Spectral AI (MDAI)
RBOT logo
Vicarious Surgical (RBOT)
DRIO logo
DarioHealth (DRIO)
NRXP logo
NRx Pharmaceuticals (NRXP)
KZR logo
Kezar Life Sciences (KZR)
OS Therapies Incorporated (OSTX)
XFOR logo
X4 Pharmaceuticals (XFOR)
  • What is the ticker symbol for Boundless Bio?
  • Does Boundless Bio pay dividends?
  • What sector is Boundless Bio in?
  • What industry is Boundless Bio in?
  • What country is Boundless Bio based in?
  • When did Boundless Bio go public?
  • Is Boundless Bio in the S&P 500?
  • Is Boundless Bio in the NASDAQ 100?
  • Is Boundless Bio in the Dow Jones?
  • When was Boundless Bio's last earnings report?
  • When does Boundless Bio report earnings?
  • Should I buy Boundless Bio stock now?

What is the ticker symbol for Boundless Bio?

The ticker symbol for Boundless Bio is NASDAQ:BOLD

Does Boundless Bio pay dividends?

No, Boundless Bio does not pay dividends

What sector is Boundless Bio in?

Boundless Bio is in the Healthcare sector

What industry is Boundless Bio in?

Boundless Bio is in the Biotechnology industry

What country is Boundless Bio based in?

Boundless Bio is headquartered in United States

When did Boundless Bio go public?

Boundless Bio's initial public offering (IPO) was on July 20, 2016

Is Boundless Bio in the S&P 500?

No, Boundless Bio is not included in the S&P 500 index

Is Boundless Bio in the NASDAQ 100?

No, Boundless Bio is not included in the NASDAQ 100 index

Is Boundless Bio in the Dow Jones?

No, Boundless Bio is not included in the Dow Jones index

When was Boundless Bio's last earnings report?

Boundless Bio's most recent earnings report was on Mar 27, 2025

When does Boundless Bio report earnings?

The next expected earnings date for Boundless Bio is May 30, 2025

Should I buy Boundless Bio stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page